Skip to main content
SpringerLink
Log in
Book cover

Cardiac Drugs in Pregnancy

  • Book
  • © 2014

Overview

Editors:
  1. Karen Sliwa

    1. Hatter Institute for Cardiovascular Research, Cape Town, South Africa

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. John Anthony

    1. Department of Obstetrics & Gynaecology, Groote Schuur Hospital, Cape Town, South Africa

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Presents up-to-date research for the treatment of cardiovascular disease during pregnancy
  • Discusses indications of drug usage in pregnancy assessing risks and benefits
  • Covers a complex treatment area in a practical, quick access format

Part of the book series: Current Cardiovascular Therapy (CCT)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. General Principles and Guidelines

    • John Anthony
    Pages 1-9

  3. Management of Hypertension

    • Eckhart J. Buchmann
    Pages 11-34

  4. Managing Heart Failure Pre- and Postpartum

    • Karen Sliwa, Kemilembe B. Tibazarwa
    Pages 35-52

  5. Management of Coronary Artery Disease and Arrhythmias

    • Annemien E. van den Bosch, Titia P. E. Ruys, Jolien W. Roos-Hesselink
    Pages 53-77

  6. Anticoagulation in Pregnancy

    • Vera Regitz-Zagrosek, Christa Gohlke-Baerwolf, Bernard Iung, Petronella G. Pieper
    Pages 79-105

  7. Obstetric Drugs in the Management of Cardiovascular Disease

    • Catherine Elliott
    Pages 107-122

  8. Back Matter

    Pages 123-131
    Download chapter PDF
Back to top

Keywords

About this book

​The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition the treatment of congenital heart disease has improved leading to an increased number of women with residual heart disease reaching childbearing age. In the western world maternal heart disease is now the major cause of maternal death during pregnancy. In the developing world rheumatic heart disease and the cardiomyopathies dominate. Those women often need anticoagulation as they might have had a valve replacement or formed a thrombus in the left heart. Drugs during pregnancy and the breastfeeding period is a complex subject and there is a profound shortage of evidence based recommendations. As drug treatment in pregnancy concern the mother and the fetus optimum treatment of both must be targeted. This book aims at discussing the most important indications of drug usage in pregnancy and postpartum with the aim of weighing the potential risk of a drug and the possible benefit against each other.​

Reviews

“This handy book, written by distinguished authors in the field, consists of six chapters illustrating pharmacological treatment of different heart diseases during pregnancy. … The book is an easy and enjoyable reading. … the content is easily comprehensible and the book has a universal appeal, as it includes treatment in countries with different facilities. In addition, the pocket format is pleasing and practical for the everyday clinician.” (Maria Schaufelberger, European Heart Journal, Vol. 36 (18), 2015)

Editors and Affiliations

  • Hatter Institute for Cardiovascular Research, Cape Town, South Africa

    Karen Sliwa

  • Department of Obstetrics & Gynaecology, Groote Schuur Hospital, Cape Town, South Africa

    John Anthony

About the editors

Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa.

Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.  

 

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation